Yongliang Zhu

机构：Second Affiliated Hospital of Zhejiang University · ORCID：0000-0001-7450-885X

发表论文 87 篇 · 总被引 3000 次 · h-index 23

代表论文

• ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes metabolic reprogramming of colorectal cancer cells (2019 · Theranostics · 被引 113)
• Alteration of the abundance of <em>Parvimonas micra</em> in the gut along the adenoma‑carcinoma sequence (2020 · Oncology Letters · 被引 41)
• ANKRD22 Drives Rapid Proliferation of Lgr5+ Cells and Acts as a Promising Therapeutic Target in Gastric Mucosal Injury (2021 · Cellular and Molecular Gastroenterology and Hepatology · 被引 37)
• ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer (2023 · Journal for ImmunoTherapy of Cancer · 被引 28)
• Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors (2021 · BMC Cancer · 被引 28)
• ANKRD22 is a novel therapeutic target for gastric mucosal injury (2022 · Biomedicine & Pharmacotherapy · 被引 21)